Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited)

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Arbuz Group LLP ("Arbuz")
Total equity attributable to the shareholders'
Total equity attributable to the shareholders'
Cumulative Effect, Period of Adoption, Adjustment
Total equity attributable to the shareholders'
Arbuz Group LLP ("Arbuz")
Common Stock
Additional paid in capital
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Arbuz Group LLP ("Arbuz")
Accumulated other comprehensive loss
Non- controlling interest
Non- controlling interest
Arbuz Group LLP ("Arbuz")
Beginning balance (in shares) at Mar. 31, 2023             59,659,191,000              
Equity, beginning of period at Mar. 31, 2023 $ 770,736 $ (22,772)   $ 777,285 $ (22,772)   $ 59 $ 164,162 $ 647,064 $ (22,772)   $ (34,000) $ (6,549)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Stock based compensation 1,233     1,233       1,233            
Disposal of FF Ukraine 0     (6,549)         (6,549)       6,549  
Purchase of Arbuz shares     $ 9,097     $ 5,457         $ 5,457     $ 3,640
Foreign currency translation adjustments, net of tax effect (1,760)     (1,760)               (1,760)    
Other comprehensive income 1,281     1,281               1,281    
Net income/(loss) 67,921     68,102         68,102       (181)  
Ending balance (in shares) at Jun. 30, 2023             59,659,191,000              
Equity, end of period at Jun. 30, 2023 $ 825,736     822,277     $ 59 165,395 691,302     (34,479) 3,459  
Beginning balance (in shares) at Mar. 31, 2024 60,321,813           60,321,813,000              
Equity, beginning of period at Mar. 31, 2024 $ 1,166,958     1,163,650     $ 60 183,788 998,740     (18,938) 3,308  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Delivered stock awards from previous year 3,092     3,092       3,092            
Stock based compensation 10,325     10,325       10,325            
Foreign currency translation adjustments, net of tax effect (65,811)     (65,811)               (65,811)    
Other comprehensive income 3,356     3,356               3,356    
Net income/(loss) $ 34,259     34,400         34,400       (141)  
Ending balance (in shares) at Jun. 30, 2024 60,721,010           60,321,813,000              
Equity, end of period at Jun. 30, 2024 $ 1,152,179     $ 1,149,012     $ 60 $ 197,205 $ 1,033,140     $ (81,393) $ 3,167